The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has ended with a flat denial from the highest court in the land.
On Monday, the Supreme Court rejected Shkreli's petition to appeal an order to return $64.6 million in profits from the pricing scheme of Daraprim, a decades-old drug used to treat toxoplasmosis. The condition is caused by a single-celled parasite that can be deadly for newborns and people with compromised immune systems, such as people who have HIV, cancer, or an organ transplant.
[...]
In a lawsuit filed in 2021, the Federal Trade Commission and seven state attorneys general accused Shkreli of building a "web of anticompetitive restrictions to box out the competition." In January of 2022, US District Court Judge Denise Cote agreed, finding that Shkreli's conduct was "egregious, deliberate, repetitive, long-running, and ultimately dangerous."Cotes banned Shkreli from the pharmaceutical industry for life and found him liable for $64.6 million in disgorgement. In January 2024, an appeals court upheld Cote's ruling.
[...]
Shkreli's lawyer filed a petition with the Supreme Court arguing that the ill-gotten profits from Daraprim's price hike went to corporate entities, not Shkreli personally, and that federal courts had issued conflicting rulings on disgorgement liabilities.In a list of orders today, the Supreme Court announced it denied Shkreli's petition to hear his appeal. The justices offered no explanation and no dissents were noted.
The denial is Shkreli's second rejection from the Supreme Court.
Previously on SoylentNews: SoylentNews Stories on Shkreli (Search Link)
Infamous Pharma Company Founded by Shkreli Files for Bankruptcy, Blames Shkreli - 20230514
Shkreli Released From Prison to Halfway House After Serving - 20220522
Judge Denies Shkreli's "Delusional Self-Aggrandizing" Plea to Get Out of Jail - 20200519
Sobbing Martin Shkreli Sentenced to 7 Years in Prison for Defrauding Investors - 20180310
FBI Arrests Shkreli of the Drug Price Hike Fame - 20151217 (That didn't take him long.)
Cost of Daraprim Medication Raised by Over 50 Times - 20150922
(Score: 2) by JoeMerchant on Friday October 11 2024, @02:18PM (3 children)
>The conviction was not for that. It was for insider trading
Kudos to the summary writer, then. First line:
🌻🌻🌻 [google.com]
(Score: 1) by khallow on Friday October 11 2024, @10:08PM (2 children)
(Score: 2) by JoeMerchant on Saturday October 12 2024, @02:02AM (1 child)
Player is gonna play... We really shouldn't be giving scumbags this much leash.
Transparency is the answer: like sex offenders, a registry of fraud and unethical business practice convictions. Anyone who trusts a business partner who appears on the registry without getting solid assurances they won't be similarly abused gets put on a similar registry: for persons who have demonstrated exceptional gullibility...
🌻🌻🌻 [google.com]
(Score: 0, Troll) by khallow on Monday October 14 2024, @01:15AM
What evidence is there that there's too much leash?
We already have that. Convictions are public record. As to gullible people, as long as you're the first name on the list - perhaps the only name on the list now that I think about it. We'll throw in your bank account numbers too. For transparency.